Study: Monopolar TURP utilization on the declineAlthough monopolar transurethral resection of the prostate remains the standard of care for bladder outlet obstruction secondary to BPH, its utilization has decreased in recent years, according to a recent study.
Bipolar TURP associated with ‘substantial’ cost savingsBipolar transurethral resection of the prostate offers an economic benefit compared with monopolar TURP that follows from the clinical differences between the two procedures, concluded investigators who presented their findings at the 2017 Western Section of the AUA annual meeting in Vancouver, BC.
Study: BPH procedure’s benefits sustained at 3 yearsThe prostatic urethral lift (PUL [UroLift, NeoTract, Inc.]) yields successful 3-year durability and superior rate of improvement of BPH symptoms compared to transurethral resection of the prostate, according to separate studies presented at the AUA annual meeting in New Orleans.
Removal of cancer-free testicle prompts lawsuitWhile it is often difficult to defend a case involving the removal of an organ for cancer that is then determined to be cancer free, the added claim of lack of informed consent for the procedure does not aid the defense in these lawsuits.
Study: Safety, efficacy similar between PVP, TURPPhotoselective vaporization of the prostate is non-inferior to transurethral resection of the prostate in men with benign prostatic obstruction, researchers reported at the European Association of Urology annual congress in Stockholm, Sweden.
Best of AUA 2014: BPH/LUTSRichard K. Lee, MD, MBA, presents the take home messages on BPH/LUTS from the AUA annual meeting in Orlando, FL.
Alpha-blockers top choice for first-line LUTS treatmentMost urologists turn to alpha-blockers as first-line treatment for BPH-related lower urinary tract symptoms, while transurethral resection of the prostate remains the most commonly used surgical modality, according to a recent survey.
BPH surgical modalities safe; some attributes affect outcomesAnalyses of morbidity and mortality after surgery for BPH show that the current major modalities are all safe, but also identify patient attributes associated with an increased risk of complications.
Penile implant extrusion prompts litigationOther cases discussed in this edition of "Malpractice Consult" include cecum perforated during prostatectomy, injections fail to improve Peyronie's disease, and dementia diagnosis blamed on urologic procedure.
BPH research examines inflammation's roleIs inflammation a potential target for the treatment of BPH? New research being presented at the 2014 AUA annual meeting may help answer this question.